D
Mineralys Therapeutics, Inc. MLYS
$14.25 $0.755.56%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024
Revenue -- --
Total Other Revenue -- --
Total Revenue -- --
Cost of Revenue -- --
Gross Profit -- --
SG&A Expenses 17.60% 3.83%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses -13.87% 33.07%
Operating Income 13.87% -33.07%
Income Before Tax 13.13% -37.37%
Income Tax Expenses -- --
Earnings from Continuing Operations 13.13% -37.37%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income 13.13% -37.37%
EBIT 13.87% -33.07%
EBITDA 13.88% -33.07%
EPS Basic 13.40% -36.10%
Normalized Basic EPS 13.40% -36.10%
EPS Diluted 13.40% -36.10%
Normalized Diluted EPS 13.40% -36.10%
Average Basic Shares Outstanding 0.31% 0.93%
Average Diluted Shares Outstanding 0.31% 0.93%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings